Clinical Trials Directory

Trials / Completed

CompletedNCT01638793

Capnographic Monitoring of Propofol-sedation During Colonoscopy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
528 (estimated)
Sponsor
Johann Wolfgang Goethe University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The present study is a randomized, prospective, single-blinded study. Patients presenting for colonoscopy under sedation will be included according to the statistical sample size calculation. Patients will be randomized to either group 1- capnographic monitoring or group 2- oxygenic monitoring during Propofol-based sedation for colonoscopy. Episodes of Hypoxia are documented and compared in both groups.

Conditions

Interventions

TypeNameDescription
DEVICEMicrocap (Oridion, Needham, MA, USA)
DEVICESmart Capno Line Plus O2 (Oridion, Needham, MA, USA)

Timeline

Start date
2012-06-01
Primary completion
2013-09-01
Completion
2013-09-01
First posted
2012-07-12
Last updated
2013-10-25

Locations

2 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT01638793. Inclusion in this directory is not an endorsement.

Capnographic Monitoring of Propofol-sedation During Colonoscopy (NCT01638793) · Clinical Trials Directory